News
Ozempic accidentally became a cultural phenomenon. The drug, first delivered to diabetes patients in 2017, had a huge impact ...
Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...
Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...
10d
Stocktwits on MSNTexas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat Performance
Texas Attorney General Ken Paxton said on Tuesday that he has sued pharmaceutical giant Eli Lilly and Co. (LLY) for "bribing ...
Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant Eli Lilly, accusing the company of bribing medical providers to prescribe its lucrative medications. The lawsuit ...
Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting ...
Eli Lilly’s experimental oral weight loss pill helped patients lose about 12 percent of their body weight on average in a late-stage trial, the company said Thursday, positive results but still ...
Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster weight-loss drug, Zepbound, as it targets new markets and looks to grab more ...
The change affects so-called “GLP-1” medications FDA-approved for weight loss, including brand names such as Wegovy and Zepbound. GLP-1 medications FDA-approved to treat Type 2 diabetes, such as ...
How do GLP-1s, like Zepbound or Wegovy, affect people with papillary thyroid cancer? Papillary thyroid cancer, for the most part, is very slow-growing, kind of like small prostate cancer. Ninety-five ...
Zepbound is a prescription drug used for weight management and obstructive sleep apnea. While depression was not reported in studies of Zepbound, it's still something to watch out for while using ...
The pilot program would allow state Medicaid programs and Medicare Part D insurance plans to choose to cover Ozempic, Wegovy, Mounjaro and Zepbound for weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results